Nudging success
DnaNudge and NantNudge accelerate handheld AI genomics
Imperial College London spinout DnaNudge has signed a multi-million-dollar license agreement with NantNudge to drive AI-driven handheld diagnostics.
DnaNudge and NantNudge accelerate handheld AI genomics
Imperial College London spinout DnaNudge has signed a multi-million-dollar license agreement with NantNudge to drive AI-driven handheld diagnostics.
Audio
Podcast: NASA science alum, vaccines for TB, and the generational wealth gap
In this edition: We meet an Imperial alum who is now Head of Science at NASA, discuss the generational wealth gap and find out how to tackle TB.
Easier diagnosis of childhood fever using a new rapid blood test
A simple blood test which may be able to rapidly diagnose the cause of a child’s illness could be ‘transformative’, say researchers.
Audio
Podcast: Supersonic flight, toxic pet treatments, and fighting TB with maths
In this edition: The future of supersonic flight, how toxic flea and tick products are reaching the environment, and how maths can help eradicate TB.
Low-cost ventilator set to help people in low-income countries
A new low-cost ventilator design invented during COVID-19 could address the global shortage of ventilators for other respiratory diseases.
First WHO catalogue of tuberculosis mutations developed with Imperial
The largest catalogue of tuberculosis (TB) mutations has been developed by the WHO in collaboration with Imperial.
Video
COVID-19 pandemic could significantly increase HIV, TB and malaria cases
Some regions may see deaths related to HIV, TB and malaria increase by up to 10, 20 and 36% respectively over five years due to the COVID-19 pandemic.
1
Enzyme targeted by TB antibiotic later stops the drug by destroying it
New research shows that a TB antibiotic can be inactivated by its own target.
Pregnant women with drug-resistant TB can be safely treated, says new study
Expectant mothers with drug-resistant tuberculosis (TB) can be safely treated with bedaquiline, a treatment not previously evaluated in pregnant women
£795k award supports new African research partnership tackling drug-resistant TB
The funding, awarded as part of the MRC/DFID African Research Leader scheme, brings together researchers from Imperial and the University of Namibia.